Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

Similar articles for PubMed (Select 21951984)

1.

Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressant.

Laughren TP, Gobburu J, Temple RJ, Unger EF, Bhattaram A, Dinh PV, Fossom L, Hung HM, Klimek V, Lee JE, Levin RL, Lindberg CY, Mathis M, Rosloff BN, Wang SJ, Wang Y, Yang P, Yu B, Zhang H, Zhang L, Zineh I.

J Clin Psychiatry. 2011 Sep;72(9):1166-73. doi: 10.4088/JCP.11r06984. Review.

PMID:
21951984
2.

Vilazodone for the treatment of depression.

Lindsey WT.

Ann Pharmacother. 2011 Jul;45(7-8):946-53. doi: 10.1345/aph.1P772. Epub 2011 Jun 13. Review.

PMID:
21672888
3.

The US Food and Drug Administration's perspective on the new antidepressant vortioxetine.

Zhang J, Mathis MV, Sellers JW, Kordzakhia G, Jackson AJ, Dow A, Yang P, Fossom L, Zhu H, Patel H, Unger EF, Temple RJ.

J Clin Psychiatry. 2015 Jan;76(1):8-14. doi: 10.4088/JCP.14r09164.

PMID:
25562777
5.

Vilazodone for the treatment of major depressive disorder.

Iranikhah M, Wensel TM, Thomason AR.

Pharmacotherapy. 2012 Oct;32(10):958-65. doi: 10.1002/j.1875-9114.2012.01121.

PMID:
23033234
6.

Vilazodone hydrochloride, a combined SSRI and 5-HT1A receptor agonist for major depressive disorder.

Guay DR.

Consult Pharm. 2012 Dec;27(12):857-67. doi: 10.4140/TCP.n.2012.857. Review.

PMID:
23229074
7.

Vilazodone: a novel antidepressant.

Choi E, Zmarlicka M, Ehret MJ.

Am J Health Syst Pharm. 2012 Sep 15;69(18):1551-7. doi: 10.2146/ajhp110374. Review.

PMID:
22935937
8.

Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression.

Khan A.

Expert Opin Investig Drugs. 2009 Nov;18(11):1753-64. doi: 10.1517/13543780903286396. Review.

PMID:
19764890
9.

Vilazodone (Viibryd)--a new antidepressant.

[No authors listed]

Med Lett Drugs Ther. 2011 Jul 11;53(1368):53-4. Review.

PMID:
21738107
10.

The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder.

Reed CR, Kajdasz DK, Whalen H, Athanasiou MC, Gallipoli S, Thase ME.

Curr Med Res Opin. 2012 Jan;28(1):27-39. doi: 10.1185/03007995.2011.628303. Epub 2011 Nov 23.

PMID:
22106941
11.

Vilazodone approved for major depression.

Traynor K.

Am J Health Syst Pharm. 2011 Mar 1;68(5):366. doi: 10.2146/news110009. No abstract available.

PMID:
21330672
12.

Vilazodone: in major depressive disorder.

Frampton JE.

CNS Drugs. 2011 Jul;25(7):615-27. doi: 10.2165/11207550-000000000-00000. Review.

PMID:
21699273
13.

Vilazodone: a new treatment option for major depressive disorder.

Owen RT.

Drugs Today (Barc). 2011 Jul;47(7):531-7. doi: 10.1358/dot.2011.47.7.1622076.

PMID:
22013560
14.

Vilazodone: another novel atypical antidepressant drug.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2011 Mar;49(3):19-22. doi: 10.3928/02793695-20110203-98. Epub 2011 Feb 16.

PMID:
21323263
15.

The effect of vilazodone on sexual function during the treatment of major depressive disorder.

Clayton AH, Kennedy SH, Edwards JB, Gallipoli S, Reed CR.

J Sex Med. 2013 Oct;10(10):2465-76. doi: 10.1111/jsm.12004. Epub 2012 Dec 6.

PMID:
23216998
16.

A 1-year, open-label study assessing the safety and tolerability of vilazodone in patients with major depressive disorder.

Robinson DS, Kajdasz DK, Gallipoli S, Whalen H, Wamil A, Reed CR.

J Clin Psychopharmacol. 2011 Oct;31(5):643-6. doi: 10.1097/JCP.0b013e31822c6741.

PMID:
21869687
17.

A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder.

Khan A, Cutler AJ, Kajdasz DK, Gallipoli S, Athanasiou M, Robinson DS, Whalen H, Reed CR.

J Clin Psychiatry. 2011 Apr;72(4):441-7. doi: 10.4088/JCP.10m06596.

PMID:
21527122
18.

ACS chemical neuroscience molecule spotlight on viibryd (Vilazodone).

Hopkins CR.

ACS Chem Neurosci. 2011 Oct 19;2(10):554. doi: 10.1021/cn200084v. Review.

19.

Pharmacokinetics of vilazodone in patients with mild or moderate renal impairment.

Boinpally R, Alcorn H, Adams MH, Longstreth J, Edwards J.

Clin Drug Investig. 2013 Mar;33(3):199-206. doi: 10.1007/s40261-013-0061-5.

PMID:
23417352
20.

A review of current evidence for vilazodone in major depressive disorder.

Wang SM, Han C, Lee SJ, Patkar AA, Masand PS, Pae CU.

Int J Psychiatry Clin Pract. 2013 Aug;17(3):160-9. doi: 10.3109/13651501.2013.794245. Epub 2013 May 29. Review.

PMID:
23578403
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk